Guggenheim initiates Centrus Energy stock with buy rating on HALEU position

Guggenheim initiated coverage on Centrus Energy Corp. (NYSE:LEU) with a positive outlook, assigning the stock a buy rating and setting a price target of $167.00. The investment firm highlighted Centrus's unique position in the United States as the sole company with a pathway to providing high-assay low enriched uranium (HALEU) fuel to commercial customers.

However, Guggenheim cautioned that Centrus faces a long and costly journey to HALEU enrichment operations, estimating the firm's target multiple at 11 times its 2032 earnings before interest, taxes, depreciation, and amortization (EBITDA). At that time, Centrus expects its HALEU enrichment efforts to be at scale, and the company's current valuation is reflected in its market capitalization of $3.01 billion, trading at $147.14 per share.

Despite the overvaluation indicated by InvestingPro analysis, Centrus has proven its technical capability through operations in Piketon, Ohio, and has been profitable in the past year with more cash on its balance sheet than debt. The firm emphasizes the challenge of scaling the company's operations, as the U.S. commercial nuclear power business has seen a long decline, leaving the country without fully U.S.-owned enrichment capabilities.

Russia and China control over 60% of the global enrichment supply, and other U.S.-owned companies have yet to operate centrifuges. Centrus Energy recently announced an underwritten public offering of Class A common stock, pre-funded warrants, and common warrants, subject to market conditions and no assurance of completion. Additionally, Jefferies and Stifel provided their own coverage, assigning Centrus a Hold and Buy rating, respectively, with price targets of $169 and $216, while UBS raised its price target to $185, citing improved gross margins and revised EBITDA estimates.